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Background. Small GTPases of the Rab family can cycle between a GTP- and a GDP-bound state and also between membrane and
cytosol. The latter cycle is mediated by the Guanine Nucleotide Dissociation Inhibitor GDI, which can selectively extract GDP-
bound Rab proteins from donor membranes, and then reload them on target membranes. In previous studies, we found that
capture of the small GTPase Rab5, a key regulator of endocytic membrane traffic, by GDI is stimulated by oxidative stress via
p38MAPK, resulting in increased fluid phase endocytosis. Methodology/Principal Findings. When purifying the GDI stimulating
activity we found that that it copurified with a high MW protein complex, which included p38MAPK. Here we report the
identification and characterization of another component of this complex as the thioredoxin-like protein TXNL1. Our observations
indicate that TXNL1 play a selective role in the regulation of fluid phase endocytosis, by controlling GDI capacity to capture Rab5.
Conclusions/Significance. Oxidants, which are known to cause cellular damage, can also trigger signaling pathways, in
particular via members of the thioredoxin family. We propose that TXNL1 acts as an effector of oxidants or a redox sensor by
converting redox changes into changes of GDI capacity to capture Rab5, which in turn modulates fluid phase endocytosis.
Citation: Felberbaum-Corti M, Morel E, Cavalli V, Vilbois F, Gruenberg J (2007) The Redox Sensor TXNL1 Plays a Regulatory Role in Fluid Phase
Endocytosis. PLoS ONE 2(11): e1144. doi:10.1371/journal.pone.0001144
INTRODUCTION
Cellular uptake of particles, solutes, lipids, and membrane proteins,
including receptor–ligand complexes is mediated by clathrin-
dependent endocytosis, macropinocytosis and also by other
pathways, in particular rafts and caveolae [1,2]. Molecules
internalized by the clathrin pathway, and by at least some of the
other routes, are delivered to early endosomes, where sorting
occurs. Some molecules are then recycled back to the plasma
membranes, e.g. housekeeping receptors, or transported to the
trans-Golgi network, while others, like the downregulated signaling
receptors, are transported to late endosomes and then lysosomes for
degradation [3]. Compelling evidence now shows that signaling
pathways control many endocytic transport steps [4,5,6]. In
particular, a genome-wide analysis has revealed that an un-
expectedly high number of kinases are implicated in clathrin and
caveolar/raft endocytosis [5]. Further, many of these ‘‘endocytic’’
kinases also function in various signaling pathways, strengthening
the notion that endocytosis and signaling are tightly coupled [5].
The small GTPase Rab5 plays a crucial role in the cross talk
between endocytic membrane traffic and signaling. This GTPase
regulates early endocytic events [7], and coordinates entry into the
cells by endocytosis and macropinocytosis, in particular via its
effector Rabankyrin-5 [8]. Like other GTPases, Rab5 cycles
between GTP- and GDP-bound states, and, interacts in the active
GTP-bound state with its effectors, which mediates Rab5-
dependent functions. In addition, GTPases of the Rab family
can also cycle between membrane and cytosol via the Guanine
nucleotide Dissociation Inhibitor (GDI). GDI has the capacity to
extract Rab proteins in their inactive GDP-bound state from
cellular membranes, and then to deliver them to their appropriate
target membranes. We previously found that p38MAPK phos-
phorylates GDI and thereby increases GDI capacity to capture
early endosomal Rab5, which in turn stimulates endocytosis
[9,10], presumably by increasing Rab5 cycling rates. Similarly,
long term depression (LTD) triggers p38MAPK activation and
leads to AMPA receptor endocytosis, probably by stimulating
GDI:Rab5 complex formation [11] or by directly activating Rab5
at the plasma membrane [12]. p38MAPK activation is also
required and sufficient for endocytosis of the m-opioid receptor
[13] and the epidermal growth factor receptor (EGFR) [14,15], via
phosphorylation of the Rab5 effector EEA1 [13] and EGFR [15],
respectively. Consistently, silencing several kinases involved in
clathrin endocytosis induces p38MAPK phosphorylation and its
association with endosome-like structures [5].
Here, we report that the thioredoxin-like protein TXNL1
modulates GDI functions in the cycle of Rab5 and regulates fluid
phase endocytosis. At steady state (under cytosolic reducing
conditions), TXNL1 is found in the cytosol partially associated
both with p38MAPK and with GDI. A fraction of TXNL1 and
p38MAPK is also associated with early endosomes, where TXNL1
may interfere with the capture of Rab5 by GDI.
RESULTS
p38MAPK and TXNL1
We previously reported that a cytosolic activity stimulates the
capacity of GDI to capture and extract Rab5 from early
endosomal membranes [9]. This activity eluted at a high
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below) and was recovered following purification, in a fraction
containing 5 major polypeptides, including p38MAPK [9]. Since
p38MAPK alone could activate GDI [9], polypeptides co-
purifying with p38MAPK presumably fulfill regulatory functions.
Amongst these, we identified by tandem mass spectrometry
TXNL1 or TRP32 (thioredoxin-related protein of 32 kDa)
[16,17]—a protein that had been previously implicated in the
cellular response to sugar starvation stress [18]. TXNL1 is an
ubiquitous protein with a N-terminal thioredoxin-like domain [19]
and a C-domain of unknown functions (see Fig 1D). When
ectopically expressed, FLAG-tagged TXNL1 co-immunoprecipi-
tated His6-p38 and vice versa, but with low efficiency (Fig 1C).
This suggests that a minor fraction only of these proteins formed
a presumably transient complex—endogenous TXNL1 could not
be immunoprecipitated with our antibodies. Importantly, howev-
er, after gel filtration of rat liver cytosol, the bulk of endogenous
TXNL1 was recovered in high MW fractions (Fig 1A fractions 4-5,
red symbols), well separated from the position of the TXNL1
monomer (Fig 1A, fraction 8-9). In fractions 4-5, the high MW
form of TXNL1 co-purified with a portion of endogenous
p38MAPK (Fig 1A fractions 4-5, blue symbols) and with the
GDI stimulating activity (Fig 1B, fractions 4-5). The bulk of
p38MAPK eluted at the position of the monomer (Fig 1A,
fractions 8-9), as expected since p38MAPK is involved in many
cellular responses and only a minor fraction of total p38MAPK
may be involved in this pathway. In addition, p38MAPK
association with the complex may be relatively labile. In any
case, this suggests that TXNL1 is part of a protein complex that
contains p38MAPK and exhibits GDI stimulating activity.
TXNL1 redox activity
Since TXNL1 contains an N-terminal thioredoxin-like domain,
including the conserved CGPC (Fig 1D) catalytic site, we
investigated whether the purified recombinant protein could
reduce the disulfide bonds of insulin in the presence of
dithiothreitol, hence whether it was catalytically active. We also
used a truncated version of TXNL1 corresponding to the N-
terminal domain containing the thioredoxin-like domain (GST-
TXNL1-N, residues 1–122), as well as the C-terminal domain
alone (GST-TXNL1-C, residues 105–289). Both full length GST-
TXNL1 and TXLN1 (after GST cleavage) exhibited reducing
activity in vitro when compared to thioredoxin (TRX), as did the
N-domain of TXNL1 (GST-TXNL1-N), but not the C-domain of
TXNL1 (GST-TXNL1-C), as expected [19] (Fig 1D). Moreover,
mutation of the two conserved cysteine residues in the CGPC
motif to serines (C34,37S) abolished GST-TXNL1 and GST-
TXNL1-N ability to reduce insulin (Fig 1D), indicating that the N-
terminal thioredoxin-like domain of TXNL1 exhibits catalytic
activity, and is thus functionally related to thioredoxin.
TXNL1 and phospho-p38MAPK are partially
associated with early endosomes
TXNL1 is primarily a cytosolic protein [16], but small amounts
(,5% total) co-sedimented with membranes (not shown). After
floatation in gradients, the endogenous form of membrane-
associated TXNL1 co-purified with Rab5 and its effectors
Rabankyrin-5 (Fig 2A) and EEA1 (Fig 2B, solid arrow) in early
endosomal fractions, as did the ectopically expressed FLAG-
tagged form (Fig 2B, open arrow). Similarly, a minor fraction of
phospho-p38MAPK could be detected on Rab5-containing early
endosomes at steady state by immunofluorescence (Fig 2D)-but not
by western blotting when detection was limiting (Fig 2A).
Detection of p38MAPK was specific, since the signal was not
observed when the primary antibody was omitted (Fig 2E).
We previously showed that oxidative stress partially releases
Rab5 (bound to GDI) from endosomes, and that this, in turn,
causes the dissociation of EEA1 ([9] and Fig 2B). When activated,
phosphorylated p38MAPK becomes mainly translocated to the
nucleus (not shown; see also [9] and references therein) but
interestingly we found that amounts of endosome-associated
phospho-p38MAPK also increased significantly after oxidative
stress (Fig 2A and 2C). Under stress conditions, a temporal
sequence may thus control the transient action of active p38 on
GDI:Rab5 before transit to the nucleus. In contrast, endosomal
association of endogenous and FLAG-tagged TXNL1 was
independent of the stress response (Fig 2A and 2B). Moreover,
mutation of the two conserved cysteines in the CGPC catalytic site
of the thioredoxin domain (TXNL1
C34,37S) inhibited TXNL1
reducing activity (Fig 1D), but did not affect TXNL1 endosome
association, whether or not cells were submitted to oxidative stress
(Fig 2B).
Rab5 capture by GDI is modulated by TXNL1
We then investigated whether TXNL1 modulated the capacity of
GDI to extract Rab5 from purified early endosomes. We found
that formation of the Rab5:GDI complex was inhibited by cytosol
prepared from cells overexpressing TXNL1, but not by cytosol
from mock-transfected cells or from cells overexpressing the Rab5
effector Rabankyrin-5 (Fig 3A). This TXNL1-dependent in-
hibition was only observed with freshly prepared cytosol pre-
sumably because TXNL1 became oxidized during storage—
a process that would not occur in vivo in the reducing environment
of the cytosol. We thus tested whether the regulatory function of
TXNL1 depended on its redox state. While the addition of the
pre-reduced form of recombinant TXNL1 to control cytosol
inhibited Rab5 extraction, the pre-oxidized form did not interfere
with GDI activity (Fig 3B). Neither did the recombinant
catalytically inactive TXNL1
C34,37S mutant Fig 3B), which
presumably mimics a constitutively oxidized state [20]. We could
not determine whether TXNL1 also regulates the capacity of GDI
to capture other Rab proteins, because the detection was limiting
with the antibodies against other Rab proteins that we had
available. Clearly, it will be important to determine whether the
same mechanism only controls endocytosis via Rab5, or controls
selective transport steps via a sub-set of Rabs, or whether this
mechanism operates in a more general manner in membrane
traffic regulation. Our observations thus indicate that, in its
reduced form, TXNL1 negatively regulates the activity of GDI to
capture Rab5 in vitro, and suggest that TXNL1 regulatory
functions depend on its catalytic activity hence its capacity to
cycle between oxidized and reduced states.
TXNL1 interactions with GDI:Rab5 and GDI
Our observations that TXNL1 regulates GDI activity suggest that
TXNL1 interacts with GDI and perhaps with the GDI:Rab5
complex. Indeed, all Rab5 is bound to GDI in the cytosol [10],
while only a minor fraction of GDI is complexed to Rab5 (GDI is
an abundant protein). We thus tested whether, cytosolic Rab5
(bound to GDI) co-purified after pulldown with WT GST-TXNL1
or with the GST-TXNL1
C34,37S mutant, which presumably
mimics a constitutively oxidized state. Surprisingly, Rab5 co-
purified with both WT and mutant forms, but only in the presence
of H2O2 (Fig 3C). This was not due to artificial cross-linking via
trans disulfide bridges, since Rab5 mobility was unaffected in non-
reducing gels (not shown). Neither were these interactions due to
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PLoS ONE | www.plosone.org 2 November 2007 | Issue 11 | e1144Figure 1. TXNL1 and p38MAPK. (A) Rat liver cytosol (RLC, 30 mg) was precipitated in 30% (NH4)2SO4 (P30). The precipitate was fractionated by gel
filtration chromatography on a Superose 12 column, and fractions analyzed by western blotting. The lower panel shows the densitometric scan of the
gels in the upper panel (red squares: TXNL1; blue triangles: p38MAPK). Arrows point at calibration markers: ferritin 440 kDa; aldolase 156 kDa;
albumin 67 kDa. The bulk of GDI is associated with Rab proteins [10] and is thus present as complexes of <80 kD [22], which elute in fractions 8-9 on
the Superose 12 column. (B) The Superose 12 fractions (A) were pooled 2 by 2 and assayed for their capacity to stimulate 1 mM GST-GDI to extract
early endosomal Rab5 [39]. After endosome removal on gradients, GST-GDI with bound Rab5 was retrieved onto glutathione beads and analyzed by
western blotting. For comparison, the activity of 100 mg RLC or P30 is shown. The fractionation (A) and analysis (B) was repeated 3 times, and
representative examples are shown. (C) HeLa cells were co-transfected with Flag-TXNL1 and His6-p38MAPK. Immunoprecipitation (IP) from lysates
(lys: 5% of total) was with (+) or without (2) the indicated antibodies, and analysis was by western blotting. Each experiment was repeated at least 3
times, and (C) shows a representative example. (D) The outline of TXNL1 is shown with the CPGC motif in the TRX-like N-terminal domain (residues 1–
107). Purified recombinant proteins were assayed (5 mM) before or after GST cleavage for their capacity to reduce insulin disulfide bonds in the
presence of dithiothreitol, using dithiothreitol alone as a control (CTRL). Data are normalized to values obtained with E.Coli thioredoxin (TRX).
doi:10.1371/journal.pone.0001144.g001
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TXNL1 or GST-TXNL1
C34, 37S (Fig 3D). Indeed, TXNL1 pulled
down GDI equally well under reducing or oxidizing conditions—
as did TXNL1
C34, 37S (Fig 3D), ruling out the possibility that
TXNL1 was artificially cross-linked to GDI in vitro. Hence,
TXNL1 independently of its redox state seemed to have the
capacity to interact directly or indirectly with cytosolic GDI—as it
did with endosomal membranes (Fig 2B). This interaction required
full-length TXNL1, since neither the catalytic active N-domain
(Fig 1D) nor the C-domain alone pulled down GDI (Fig 3E). We
thus conclude that, while TXNL1 can interact with GDI
independently of its redox state (Fig 3D), peroxide triggers or
stabilizes direct or indirect interactions with the GDI:Rab5
complex (Fig 3C). Oxidative conditions may thus facilitate
TXNL1 interactions with the cytosolic GDI:Rab5 complex
(Fig 3C), concomitantly with increased Rab5 capture by GDI
[9] and decreased GDI membrane-association [21].
It should be noted that in our gel filtration analysis (Fig 1A) we
used a Superose 12 column, which does not provide sufficient
resolution in the low MW range to separate GDI associated with
Rab proteins [10] as complexes of <80 kD [22] from a putative
complex of GDI:Rab5 with TXNL1. Moreover, this complex
Figure 2. Association with early endosomes. (A) Early endosomes were prepared from BHK cells treated or not for 10 min with 0.05 or 1 mM H2O2
[39], and analyzed by western blotting. (B) Experiments were as in (A), but cells were transfected with Flag-TXNL1 or Flag-TXNL1
C34,37S. Open and
solid arrows point at Flag-tagged and endogenous TXNL1, respectively. Each experiment in (C) and (D) was repeated at least 5 times, and
representative examples are shown. (C) Phospho-p38MAPK present in early endosomal fractions was quantified after lysis in 1% TX100 by sandwich
ELISA (expressed as OD units per mg protein). The figure shows the mean of 3 experiments. Error bars represent standard deviations; the observed
differences are significant according to Student’s t test with p,0.0001 at each H2O2 concentration. (D) HeLa cells were analyzed by
immunofluorescence using antibodies against phospho-p38MAPK (pp38) and Rab5, followed by labeled secondary antibodies. Arrows point at
examples of endosomes containing both Rab5 and pp38 (see inset). A fraction of pp38MAPK colocalized with Rab5 on early endosomes, but we were
unable to unambiguously localize pp38MAPK on the membrane of other organelles using various markers, presumably because detection was
limiting. (E) Cells were processed as in (D), except that primary antibodies against phospho-p38MAPK were omitted, and then analyzed in the red
channel.
doi:10.1371/journal.pone.0001144.g002
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interacts with most Rab proteins [7].
TXNL1 regulates endocytosis
Since TXNL1 appears to regulate Rab5 capture by GDI and to
interact with GDI:Rab5, we investigated TXNL1 potential role
during endocytosis in vivo. To this end, uptake of the fluid phase
tracer horseradish peroxidase (HRP) was quantified over short
time-periods to ensure that only internalization was being
monitored, rather than more distal transport steps. Knockdown
of TXNL1 with dicer-generated siRNA duplexes (Fig 3F) did not
interfere with HRP uptake, except perhaps by causing a small,
marginal increase (Fig 4A) in line with the inhibitory effect of
reduced TXNL1 in vitro (Fig 3B). Strikingly, overexpression of
TXNL1
C34,37S—the catalytically inactive mutant that presumably
mimics the oxidized state—caused a marked (<200%) increase in
endocytosis (Fig 4B), consistently with observations that oxidative
conditions accelerate endocytosis and facilitate Rab5 capture by
GDI [9] as well as TXNL1 interactions with the GDI:Rab5
complex. Some stimulation was also observed with WT TXNL1
(overexpressed to the same levels as TXNL1
C34,37S, Fig 2B),
presumably reflecting TXNL1 capacity to cycle from reduced to
Figure 3. Rab5 capture by GDI is modulated by TXNL1. (A) The capture of early endosomal Rab5 by GDI was analyzed. In the assay, GST-GDI was
incubated with early endosomes in the absence (2) or presence of cytosol prepared from mock-transfected cells (mock), or from cells overexpressing
either the Rab5 effector Rabankyrin-5 (RabAnk-5) or TXNL1. Rab5 bound to GDI was then retrieved and analyzed as in Fig 1B. The experiment was
repeated 3 times, and a representative example is shown. (B) The capture of early endosomal Rab5 by GDI was analyzed as in (A), except that the
assay was in the absence (2) or presence (+) of rat liver cytosol and 500 nM recombinant TXNL1 or TXNL1
C34, 37S (after GST removal). Recombinant
proteins were pre-reduced for 30 min with 1 mM DTT on ice (reducing conditions), or pre-oxidized for 15 min with 10 mM H2O2 at 25uC (oxidizing
conditions). In both cases, proteins were then diluted 12 fold in the reaction mixture and the same final DTT or H2O2 concentrations were used when
TXNL1 or TXNL1
C34, 37 were omitted. These experiments were repeated 5 times, and representative examples are shown (C) Pulldown of rat liver
cytosol (RLC) using purified GST fusion proteins that were (+) or not (2) pre-oxidized (Ox) as in (B). GST-proteins were retrieved onto immobilized
beads and analyzed by western blotting with anti-Rab5 antibodies (all lanes are from the same gel). These experiments were repeated 4 times, and
representative examples are shown. All lanes in the panel are from the same experiment. (D) Pulldown of rat liver cytosol (RLC) using purified GST-
fusion proteins that were (+) or not (2) pre-reduced (Red) or pre-oxidized (Ox) as in (B). Analysis was by western blotting with anti-GST or anti-GDI
antibodies. These experiments were repeated 3 times, and representative examples are shown (E) Pulldowns with GST-fusion proteins (C, and see
Fig 1D) were analyzed by western blotting with anti-GDI antibodies. These experiments were repeated 3 times, and representative examples are
shown (F) HeLa cells were either mock transfected or transfected with siRNA duplexes for 72 h (MGC2477 hypothetical protein as RNAi control). Total
cell-extracts were analyzed by western blotting with the indicated antibodies.
doi:10.1371/journal.pone.0001144.g003
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creased endocytosis in vivo, while reduced TXNL1 was inhibitory
in vitro (Fig 3B). Consistently, TXNL1 overexpression did not
cause Rab5 release from membranes (not shown), hence did not
lead to GDI activation, demonstrating that TXNL1 levels are not
limiting. By contrast, overexpression of TXNL1 or TXNL1
C34,37S
Figure 4. TXNL1 regulates fluid phase endocytosis. (A) HRP uptake for 5 min at 37uC was quantified in HeLa cells either mock-transfected or
transfected with TXNL1-siRNA duplexes. Data are normalized to the uptake in mock-treated cells and are representative of at least three independent
experiments (each in duplicate). The error bar represents the standard deviation; the observed differences are significant according to Student’s t test
with p,0.005 (B) HeLa cells were either mock transfected or transfected with Flag-TXNL1 or Flag-TXNL1
C34, 37S. Cells were incubated with HRP for
5 min at 37uC and analyzed as in (A). The figure shows the mean of 3 independent experiments. Error bars represent the standard deviation; the
observed differences are significant according to Student’s t test with p,0.0001 under each condition (C–D) HeLa cells were either mock transfected
or transfected with Flag-TXNL1 or Flag-TXNL1
C34, 37S, as in (B), incubated with rhodamine-labeled transferrin (Tf), processed for immunofluorescence
using anti-flag antibodies and visualized by double-channel fluorescence microscopy (D). The number of transferrin-containing endosomes was
counted in 20 cells of duplicate samples in 3 independent experiments (as in D) and the quantification is shown in (C). Error bars represent the
standard deviation; the observed differences after TXNL1
C34, 37S overexpression are significant (p,0.01), but not after TXNL1 overexpression (p,0.2).
doi:10.1371/journal.pone.0001144.g004
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receptor to any significant extent (Fig 4D)—a marginal increase
was observed with the TXNL1
C34,37S mutant (Fig 4C). These
observations suggest that the massive increase in HRP endocytosis
after TXNL1
C34,37S or WT TXNL1 overexpression occurred
primarily via a clathrin-independent pathway, presumably macro-
pinocytosis. Indeed, this pathway, which accounts for the uptake of
large volumes of fluid, can be transiently up-regulated [1] and is
under the direct control of Rab5 [8]. TXNL1 thus appears to
serve as a redox sensor that selectively controls fluid phase
endocytosis via GDI functions in the membrane-cytosol cycle of
Rab5.
DISCUSSION
Previous studies have shown that p38MAPK regulates endoyctic
membrane traffic by regulating GDI [9] and EEA1 [13] activity.
In particular, we had found that p38MAPK increases the capacity
of GDI to capture early endosomal Rab5 and stimulates
endocytosis, presumably through a net increase in Rab5 cycling
[9]. Here, we report that the thioredoxin-like protein TXNL1,
which can be associated with p38MAPK, modulates GDI
functions in the cycle of Rab5 and regulates fluid phase
endocytosis. Our observations suggest that TXNL1 functions as
an effector of oxidants or redox sensor that couples oxidative stress
to endocytosis, by converting redox changes into a specific
GDI:Rab5-mediated endocytic response (see outline, Fig 5).
Thioredoxins and the endocytic pathway
Previous studies have linked thioredoxin to the regulation of
membrane traffic in yeast. Vacuole homotypic fusion [23,24] and
the fusion of ER-derived vesicles with Golgi membranes [25]
depend on the LMA1 (low molecular weight activity 1) complex
composed of thioredoxin and the cytosolic proteinase B inhibitor
I
B
2. Thioredoxin catalytic activity appears to be dispensable for
this role in membrane fusion [26]. Since we find that TXNL1
redox activity is required, TXNL1 function appears distinct from
that of thioredoxin in fusion. Our findings rather support the view
that TXNL1 acts as a physiological regulator of GDI:Rab5-
mediated endocytic response. Our observations also suggest that
TXNL1 controls some, but not all, Rab5 functions, since TXNL1
primarily regulates fluid phase uptake, while Rab5 plays a dual
role in endocytosis and macropinocytosis [8].
It is tempting to speculate that TXNL1 selectively regulates
Rab5 cycling to and from specific endosomal effector platforms,
presumably containing Rabankyrin-5 [8], involved in macropino-
cytosis regulation (see outline Fig 5). In the GTP-bound state,
Rab5 can recruit its effectors (see outline Fig 5), and after GTP
hydrolysis, inactive GDP-bound Rab5 is extracted by GDI [7], We
previously reported that this process is stimulated by the action of
p38MAPK [9]. We propose that, at steady state, i.e. under
cytosolic reducing conditions, TXNL1 is found in the cytosol
partially associated both with p38MAPK and with GDI, while
a fraction of TXNL1 and p38MAPK are also associated with
endosomal membranes. There, TXNL1 may interfere with GDI-
mediated Rab5 extraction. This inhibitory function may be
released by intracellular redox changes and TXNL1 oxidation,
leading to increased activation of GDI on membranes via
p38MAPK [9]. We thus conclude that TXNL1 functions as an
effector of oxidants or a redox sensor that selectively couples
oxidative stress and redox changes into GDI:Rab5-mediated
response in fluid phase endocytosis. This mechanism may
contribute to control the turnover of membrane components for
repair or degradation after stress.
Thioredoxins as ROS effectors
Disturbed intracellular redox balance, also known as ‘‘oxidative
stress’’, is characterized by increased intracellular concentrations
of highly reactive, oxidizing species, known as ROS (reactive
oxygen species) and RNS (reactive nitrogen species). Cells can
intentionally produce ROS during host defense and inflammatory
response. However, in many instances ROS production may also
fulfill signaling purposes [27,28]. For instance, ROS-induced
cystein oxidation is now considered a reversible and rapid
modification that regulates protein functions [27,29]. Further,
oxidant species modulate the activity of two antioxidant proteins,
namely peroxiredoxin [30] [31] and thioredoxin [32,33], suggest-
ing the existence of a dynamic crosstalk between ROS and ROS-
scavenging system.
Thioredoxins (Trx) are the major dithiol reductants present in
the cytosol [34] and act mainly as antioxidants by protecting
cytosolic proteins from ROS-induced oxidative damages [35] and
by directly scavenging ROS. However, thioredoxins, which are
highly susceptible to ROS-induced oxidation, may also play an
important role as effectors of oxidants. For instance, thioredoxin1
has redox-dependent inhibitory functions on ASK1 [36],
a MAPKKK that activates JNK and p38MAPK and mediates
stress-induced apoptosis. Similarly, the redox-sensitive interaction
of nucleoredoxin—a thioredoxin-like protein with reducing
activity—with Dishevelled probably regulates ROS-induced
Wnt-ß-catenin signaling [37]. Finally, the thioredoxin-like protein
PICOT/TXNL2 (protein kinase C-interacting cousin of thior-
edoxin), which presumably lacks enzymatic activity, interacts with
protein kinase C-theta (PKCh) inhibiting its activation of JNK/
AP1 and NF-kB, probably by competing with thioredoxin or
thioredoxin-reductase for substrate binding [38]. Future work will
Figure 5. The TXNL1 cycle. The model outlines the proposed
mechanism by which TXNL1 may regulate fluid phase endocytosis, by
modulating GDI function in the membrane-cytosol cycle of Rab5. See
text for further explanations. P38, p38MAPK; pP38, phosphorylated
p38MAPK; GDI, Guanine nucleotide Dissociation Inhibitor; pGDI;
phosphorylated GDI; Rab5:GTP or GDP, Rab5 in the GTP- or GDP-
bound state, respectively.
doi:10.1371/journal.pone.0001144.g005
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share a similar domain organization and mass, act as selective
effectors of the stress pathways regulated by JNK and p38MAPK,
respectively, although PICOT carries critical mutations in the
thioredoxin-like active site. These observations highlight possible
general functions of thioredoxin family members as redox sensors
or regulators in signaling pathways that couple oxidative stress to
cellular responses.
MATERIALS AND METHODS
Cells, antibodies and reagents
Baby Hamster Kidney cells (BHK21) and HeLa cells were grown
as described [9,39]. Monoclonal antibodies were obtained from:
His6 from Roche Diagnostics (Basel, CH); GST from Santa-Cruz
Biotechnology, Inc. (San Diego, CA); TXNL1 from Abcam
(Cambridge, UK); Rab5 and GDI from Reinhard Jahn (Go ¨ttin-
gen, Germany); FlagM2 from Sigma Chemical Co. (St. Louis,
MO); polyclonal antibodies against phospho-p38 and p38 were
from Cell Signaling (Beverly, MA); fluorescently labeled secondary
antibodies were from Jackson Immunoresearch Laboratories (West
Grove, PA). The peptide KCSTKEIPIIKFDLNK, corresponding
to a conserved C-terminal region of Rabankyrin-5 (amino acids
1136–1151) was used to raise a polyclonal antibody (Ab 16KK) in
rabbits (CovalAb, Oullins Cedex, France). Glycerol 2-phosphate,
Sodium Orthovanadate, ATP, GDP, hydrogen peroxide, horse-
radish peroxidase (HRP), o-dianisidine, recombinant E. Coli
thioredoxin and bovine insulin were from Sigma Chemical Co.
(St. Louis, MO); glutathione-Sepharose 4B beads, Benzamidine,
Sepharose 4 fast flow, Factor Xa from Amersham (UK);
transferrin-rhodamine from Molecular Probes (Eugene, OR);
okadaic acid from Calbiochem (San Diego, CA); FuGene6 from
Roche Diagnostics (Basel, CH). Oligonucleotides were synthesized
by Eurogentec SA (Seraing, BE).
Plasmids and recombinant proteins
pGEX-2T-1 with the bovine aGDI was from M Zerial, (Dresden,
Germany), PME18S-Flag-TXNL1 (TRP32) from KK Lee (Kyoto,
Japan), and pCNA3.1 His-p38a from K Tamura (San Diego, La
Jolla, CA). Generation of point mutants was carried out with the
Quick-Change Site-Directed Mutagenesis kit (Stratagene, San
Diego, La Jolla, CA). Truncated TXNL1 corresponding to the N-
terminal (residues 1–122) and C-terminal (residues 105–289)
domains were generated by PCR. GST-TXNL1 proteins were
expressed in BL21 (Stratagene) cells and purified according to the
manufacturer’s instructions (Amersham). GST-GDI was produced
using BL21(DE3)plysS bacteria (Stratagene) [39]. When indicated,
the GST tag was cleaved by Factor Xa, which was then removed
using Benzamidine Sepharose 4 fast flow according to the
manufacturer’s instructions (Amersham).
In vivo experiments
TXNL1 expression was silenced in HeLa cells by Dicer-generated
siRNA duplexes. Briefly, after PCR amplification to generate T7
promoter-based DNA templates, the target sequence (nucleotide
181–760) was transcribed in vitro to generate dsRNA. Dycing
reaction and purification of d-siRNAs were according to the
manufacturer’s instructions (Invitrogen, Carlsbad, CA). Cells were
transfected with d-siRNA using Lipofectamine 2000 24 h after
seeding, and 24 h later they were split and grown for an additional
48 h time period (total time of silencing: 72 h). DNA transfection
was performed with either Fugene6 or CaPO4 24 h after seeding
and cells were incubated for 36 h.
In vitro experiments
Rat liver cytosol (RLC) preparation and endosome fractionation
by floatation in sucrose gradients were described [39], and
performed in the presence of inhibitors of proteases (10 mg/ml
aprotinin, 10 mM leupeptin and 1 mM pepstatin) and phospha-
tases (0.1 mM vanadate and 50 mM glycerol 2-phosphate or
1 mM okadaic acid). RLC was fractionated by (NH4)2SO4
precipitation and gel chromatography on a Superose 12 column
using the SMART system [9]. The assay measuring the capture of
Rab5 from purified early endosomes by recombinant GDI was
described [9,39]. Briefly, 20 mg purified early endosomes were
incubated for 20 min at 30uC in EEB (75 mM K-Acetate, 30 mM
HEPES pH 7.4, 5 mM MgCl2) containing 0.3 mM ATP, 3 mM
GDP, 1 mM GST-GDI and 100 mg cytosol. When indicated, the
reaction mixture was supplemented with 500 nM recombinant
TXNL1 or TXNL1
C34, 37S (after GST removal) that were either
pre-reduced with 1 mM DTT (30 min, on ice) or pre-oxidized
with 10 mM H2O2 (15 min, 25uC). The mixture was then
adjusted to 40.6% sucrose, transferred to a TLS55 centrifuge
tube and overlaid sequentially with 35% sucrose solution, then
with HB (8.6%, w/w sucrose in H2O). The gradient was
centrifuged at 1700006g for 1 h at 4uC. After centrifugation,
GST-GDI with bound Rab5 was found in the load of the gradient
— well separated from Rab5 still associated with endosomes,
which floated to the 35-HB interface. GST-GDI was then
recovered onto glutathione-Sepharose beads, which were then
resuspended in SDS gel sample buffer and Rab5 bound to GST-
GDI was analyzed by SDS-PAGE and western blotting.
For immunopreciptation, Fugene-transfected HeLa cells were
lysed in TNE buffer (20 mM Tris pH 7.4, 150 mM NaCl, 1 mM
EDTA) containing 10% glycerol, 1% NP-40, and proteases
inhibitors. Lysates were pre-cleared on protein-A Sepharose
beads, divided and then incubated with or without the indicated
antibodies for 2 h, and then for 1 h with protein-A Sepharose
beads. Beads were washed with TNE containing glycerol,
resuspended in sample buffer and analyzed by SDS-PAGE and
western blotting.
In GST pulldowns, pre-cleared RLC was incubated with 60 nM
GST fusion proteins for 2 h in HB. When indicated, the
recombinant proteins were either pre-reduced with 1 mM DTT
(30 min, on ice) or pre-oxidized with 10 mM H2O2 (15 min, 25uC).
Complexes were recovered onto glutathione-Sepharose beads,
washedwithEEBandanalyzedbySDS-PAGEandwesternblotting.
Other techniques
Activation of p38MAPK by oxidative stress [9,39], quantification
of endocytosis with HRP [39] and immunofluorescence [9] were
described. Phospho-p38 was measured using an ELISA kit
according to the manufacturer’s instructions (Cell Signaling,
Beverly, MA). Briefly, BHK cells were homogenized in the
presence of 10 mg/ml aprotinin, 10 mM leupeptin, 1 mM pep-
statin, 1 mM Vanadate and 1 mM ß-Glycerophosphate. After
fractionation by flotation in a sucrose step gradient, 5 mg early
endosomes were lysed in 1% TX100 and used in the assay. Insulin
disulfide reduction assay was performed essentially as described in
[19,40]. Briefly, 0.13 mM bovine insulin were mixed with 5 mM
recombinant protein in 0.1 M potassium phosphate pH 7.0,
2 mM EDTA. The reaction was started by adding 2.5 mM DTT
and insulin reduction was monitored by recording the absorbance
at 600 nm at RT. The nonenzymatic reduction of insulin by DTT
was recorded as a control. TXNL1 was identified by tandem mass
spectrometry [9] (peptide sequences: GYMDLMPFINK, ID-
QYQGADAVGLEEK, FQNVNSVTIFVQSNQGEEETTR).
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